{{Rsnum
|rsid=7578326
|Gene=LOC646736
|Chromosome=2
|position=226155937
|Orientation=plus
|GMAF=0.3044
|Gene_s=LOC646736
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 44.2 | 41.6 | 14.2
| HCB | 75.2 | 24.1 | 0.7
| JPT | 69.0 | 27.4 | 3.5
| YRI | 38.4 | 42.5 | 19.2
| ASW | 39.3 | 50.0 | 10.7
| CHB | 75.2 | 24.1 | 0.7
| CHD | 77.1 | 22.0 | 0.9
| GIH | 71.3 | 27.7 | 1.0
| LWK | 37.3 | 46.4 | 16.4
| MEX | 56.9 | 37.9 | 5.2
| MKK | 41.7 | 47.4 | 10.9
| TSI | 39.2 | 50.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20581827
|Trait=Type 2 diabetes
|Title=Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
|RiskAllele=A
|Pval=5E-20
|OR=1.11
|ORtxt=[1.08-1.13]
|OA=1
}}

{{PMID Auto
|PMID=20043853
|Title=Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus.
|OA=1
}}

{{PMID Auto
|PMID=21278902
|Title=Genetic risk profiling for prediction of type 2 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=23462794
|Title=Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}